Evidence map›Paper›PMID 25136123›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damage.

James E Cleaver, Angela M Brennan-Minnella, Raymond A Swanson, Ka-wing Fong, Junjie Chen, Kai-ming Chou, Yih-wen Chen, Ingrid Revet, Vladimir Bezrookove

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. RNA binding proteinScience advances · 2026
    Article
  3. Article
  4. Article
  5. Mitochondrial HNature communications · 2024
    Article
  6. Review
  7. Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Xeroderma Pigmentosum: A Model for Human Premature Aging.The Journal of investigative dermatology · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

James E CleaverDepartment of Dermatology, University of California, San Francisco, CA 94143; JCleaver@cc.ucsf.edu.
Angela M Brennan-MinnellaDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, CA 94121;
Raymond A SwansonDepartment of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, CA 94121;
Ka-wing FongDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
Junjie ChenDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
Kai-ming ChouDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202;
Yih-wen ChenDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202;
Ingrid RevetDepartment of Dermatology, University of California, San Francisco, CA 94143; Department of Clinical Chemistry and Hematology, Sint Franciscus Gasthuis, 3045PM, Rotterdam, The Netherlands; and.
Vladimir BezrookoveCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, CA 94107.
University of California, San Francisco · USThe University of Texas MD Anderson Cancer Center · USCalifornia Pacific Medical Center · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Study the Role of DNA Damage Responses in Tumorigenesis and SenescenceR01CA092312 · NCI · YALE UNIVERSITY · PI CHEN, JUNJIE · 2001 to 2015
$3.5M
Mechanisms of PARP and PARG mediated cell deathR01NS041421 · NINDS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI SWANSON, RAYMOND A · 2002 to 2014
$2.9M
Regulatory Control of Glutamate - Induced Superoxide Production [Admin Supplement]R01NS081149 · NINDS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI SWANSON, RAYMOND A · 2012 to 2016
$1.7M
DNA Lesion Bypass Polymerases and Therapeutic CompoundsR01CA112446 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI CHOU, KAI-MING · 2007 to 2012
$1.1M
NCI NIH HHS CA 092312NCI NIH HHS CA 112446NCI NIH HHS R01 CA092312NCI NIH HHS R01 CA112446NINDS NIH HHS NS 041421NINDS NIH HHS R01 NS041421NINDS NIH HHS R01 NS081149PHS HHS 1R01052781
6 · The paper itself

Abstract

Cockayne syndrome (CS) is a human DNA repair-deficient disease that involves transcription coupled repair (TCR), in which three gene products, Cockayne syndrome A (CSA), Cockayne syndrome B (CSB), and ultraviolet stimulated scaffold protein A (UVSSA) cooperate in relieving RNA polymerase II arrest at damaged sites to permit repair of the template strand. Mutation of any of these three genes results in cells with increased sensitivity to UV light and defective TCR. Mutations in CSA or CSB are associated with severe neurological disease but mutations in UVSSA are for the most part only associated with increased photosensitivity. This difference raises questions about the relevance of TCR to neurological disease in CS. We find that CSB-mutated cells, but not UVSSA-deficient cells, have increased levels of intramitochondrial reactive oxygen species (ROS), especially when mitochondrial complex I is inhibited by rotenone. Increased ROS would result in oxidative damage to mitochondrial proteins, lipids, and DNA. CSB appears to behave as an electron scavenger in the mitochondria whose absence leads to increased oxidative stress. Mitochondrial ROS, however, did not cause detectable nuclear DNA damage even when base excision repair was blocked by an inhibitor of polyADP ribose polymerase. Neurodegeneration in Cockayne syndrome may therefore be associated with ROS-induced damage in the mitochondria, independent of nuclear TCR. An implication of our present results is that mitochondrial dysfunction involving ROS has a major impact on CS-B pathology, whereas nuclear TCR may have a minimal role.

Indexed as

DNA DamageCarrier ProteinsCell LineCell NucleusDNA HelicasesDNA Repair EnzymesEthidiumFibroblastsHistonesHumansHydrogen PeroxideMitochondriaOxidation-ReductionPoly-ADP-Ribose Binding ProteinsReactive Oxygen SpeciesRotenoneCarrier ProteinsdihydroethidiumDNA HelicasesDNA Repair EnzymesERCC6 protein, humanEthidiumH2AX protein, humanHistonesHydrogen PeroxidePoly-ADP-Ribose Binding ProteinsReactive Oxygen SpeciesRotenoneUVSSA protein, humanbromatecomet assayhydrogen peroxideoxidative DNA damageγH2Ax

Identifiers

PMID25136123
PMCPMC4169934
OpenAlexW2148713962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.